Ditchcarbon
  • Contact
  1. Organizations
  2. Medincell
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated a month ago

Medincell Sustainability Profile

Company website

Medincell, a pioneering biopharmaceutical company headquartered in France, focuses on the development of innovative long-acting injectable therapies. Founded in 2000, the company has made significant strides in the industry, particularly in the fields of mental health and chronic diseases. Medincell's proprietary technology platform, which enables the sustained release of active pharmaceutical ingredients, sets it apart from competitors. With a strong presence in Europe and expanding operations globally, Medincell is committed to addressing unmet medical needs through its core products, including its lead candidate for the treatment of schizophrenia. The company has garnered recognition for its unique approach to drug delivery, positioning itself as a leader in the biopharmaceutical sector. Medincell continues to advance its mission of improving patient outcomes through innovative therapeutic solutions.

DitchCarbon Score

How does Medincell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

43

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Medincell's score of 43 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Medincell's reported carbon emissions

In 2024, Medincell reported total carbon emissions of approximately 5,000,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 776 kg CO2e, primarily from mobile combustion, while Scope 2 emissions totalled approximately 40,820 kg CO2e, all from purchased electricity. The most significant contribution came from Scope 3 emissions, which amounted to around 4,500,000 kg CO2e, with major sources including purchased goods and services (approximately 4,214,400 kg CO2e) and business travel (about 212,750 kg CO2e). In 2023, Medincell's emissions were lower, with total emissions of about 5,000,000 kg CO2e, including 12,860 kg CO2e from Scope 2 and significant Scope 3 emissions of approximately 4,800,000 kg CO2e. Notably, there were no reported Scope 1 emissions in 2023. Medincell has not set specific reduction targets or initiatives as part of their climate commitments, and there are no cascading emissions data from a parent company. The company is actively working to understand and manage its carbon footprint, but further details on reduction strategies or pledges are currently unavailable.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
-
-
-
-
-
000
Scope 2
8,380
0,000
0,000
0,000
00,000
00,000
Scope 3
-
-
-
-
0,000,000
0,000,000

How Carbon Intensive is Medincell's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Medincell's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Medincell's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Medincell is in FR, which has a very low grid carbon intensity relative to other regions.

Medincell's Scope 3 Categories Breakdown

Medincell's Scope 3 emissions, which decreased by 12% last year and decreased by approximately 12% since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 74% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
74%
Capital Goods
8%
Upstream Leased Assets
8%
Downstream Leased Assets
4%
Business Travel
4%
Employee Commuting
2%
Waste Generated in Operations
<1%
Downstream Transportation & Distribution
<1%

Medincell's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Medincell has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Medincell's Emissions with Industry Peers

Dr Reddys Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Alkermes

IE
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy